Mutation of potential N-linked glycosylation sites in the Alzheimer's disease amyloid precursor protein (APP)

被引:35
|
作者
Yazaki, M
Tagawa, K
Maruyama, K
Sorimachi, H
Tsuchiya, T
Ishiura, S
Suzuki, K
机构
[1] UNIV TOKYO,INST MOL & CELLULAR BIOSCI,TOKYO 113,JAPAN
[2] SOPHIA UNIV,FAC SCI & TECHNOL,DEPT CHEM,TOKYO 102,JAPAN
[3] NATL INST PHYSIOL SCI,OKAZAKI,AICHI 444,JAPAN
关键词
amyloid; Alzheimer's disease; amyloid precursor protein; processing; glycosylation;
D O I
10.1016/S0304-3940(96)13285-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In order to study the mechanism of intracellular sorting and processing of the Alzheimer's disease amyloid precursor protein (APP), we deleted two potential N-linked glycosylation sites of APP by site-directed mutagenesis. Substitution of alanines for the critical asparagine residues Asn467 and Asn496 was performed. Wild-type and mutant APPs were expressed in COS-1 cells by cDNA transfection and the expressed of the protein products and secretion of N-terminal large fragment was observed. The initial secretion of the mutant APP appeared to be slow compared with wild-type. In addition, we found that a distinct APP fragment, the cytosolic form, is transiently increased in the cytosol fraction of COS-1 cells. These results suggest that aberrant processing occurs following the expression of a mutant APP with Ala substituted for Asn, and that glycosylation may modulate the intracellular sorting of APP. (C) 1996 Elsevier Science Ireland Ltd.
引用
收藏
页码:57 / 60
页数:4
相关论文
共 50 条
  • [31] Presenilins, β-amyloid precursor protein and the molecular basis of Alzheimer's disease
    Selkoe, DJ
    CLINICAL NEUROSCIENCE RESEARCH, 2001, 1 (1-2) : 91 - 103
  • [32] Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein
    Henry, A
    Li, QX
    Galatis, D
    Hesse, L
    Multhaup, G
    Beyreuther, K
    Masters, CL
    Cappai, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (02) : 402 - 415
  • [33] Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus
    Al-kuraishy, Hayder M.
    Sulaiman, Ghassan M.
    Mohammed, Hamdoon A.
    Dawood, Retaj A.
    Albuhadily, Ali K.
    Al-Gareeb, Ali I.
    Abomughaid, Mosleh M.
    Klionsky, Daniel J.
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2025, 45 (01)
  • [34] Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses
    Willen, Katarina
    Sroka, Agnieszka
    Takahashi, Reisuke H.
    Gouras, Gunnar K.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (02) : 511 - 524
  • [35] The Role of the Amyloid Protein Precursor (APP) in Alzheimer's Disease: Does the Normal Function of APP Explain the Topography of Neurodegeneration?
    David H. Small
    Neurochemical Research, 1998, 23 : 795 - 806
  • [36] The role of the amyloid protein precursor (APP) in Alzheimer's disease: Does the normal function of APP explain the topography of neurodegeneration?
    Small, DH
    NEUROCHEMICAL RESEARCH, 1998, 23 (05) : 795 - 806
  • [37] β-Amyloid precursor protein is detectable on monocytes and is increased in Alzheimer's disease
    Jung, SS
    Gauthier, S
    Cashman, NR
    NEUROBIOLOGY OF AGING, 1999, 20 (03) : 249 - 257
  • [38] Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer's disease and normal physiology
    Pfundstein, Grant
    Nikonenko, Alexander G.
    Sytnyk, Vladimir
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [39] Factors influencing the processing and function of the amyloid β precursor protein -: a potential therapeutic target in Alzheimer's disease?
    Coughlan, CM
    Breen, KC
    PHARMACOLOGY & THERAPEUTICS, 2000, 86 (02) : 111 - 144
  • [40] Amyloid β and APP as biomarkers for Alzheimer's disease
    Zetterberg, Henrik
    Blennow, Kaj
    Hanse, Eric
    EXPERIMENTAL GERONTOLOGY, 2010, 45 (01) : 23 - 29